Shanghai: The seventh batch of 42 drugs has price caps, affecting a large number of pharmacies

　　On August 22, Shanghai announced the seventh batch of 42 restricted pharmacy drugs to be purchased online in 2022, and the pricing of 42 drugs was included in monitoring
.
According to the news, in order to do a good job in the work related to the listing of drugs in designated pharmacies in Shanghai, according to the "Notice on Announcement of the Operational Measures for the Administration of Drug Prices in Designated Pharmacies in Shanghai" (hereinafter referred to as the "Notice") (Hu Yao Shi Yao [2021] No.
83) According to the requirements of the pharmacy, the relevant matters related to the restriction of pharmacies to be listed on the Internet are notified as follows: Drug Information Announcement August 22, 2022 Drug information will be pushed to designated pharmacies through the "Shanghai Pharmaceutical Purchasing Service and Supervision Information System" (hereinafter referred to as the Sunshine Platform), 2022 Effective August 24, 2008
.
Drug price upload The drug retail price is uploaded by the designated pharmacy through the Sunshine platform.
According to the information pushed by the Sunshine platform and the "red and yellow reminder line", combined with the relevant stipulations of the medical insurance service agreement of the designated pharmacy, the retail price is uploaded independently and the price effective date is filled in
.
Among them, the details of 42 drugs are as follows: 01 Implementation of drug price monitoring in many places In October last year, Shanghai Sunshine Pharmaceutical Purchasing Network issued Circular No.
83, and the drugs sold by designated pharmacies belong to the "Shanghai Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" For the medicines, the retail price information must be uploaded through the Sunshine platform
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product with the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
So, what is the "red and yellow prompt line"? How much room is there for price increases in designated pharmacies? Included in the drug price management of designated pharmacies are mainly divided into two levels: one is the price reminder (yellow line)
.
If the price is higher than the yellow line, the system will automatically remind
.
The yellow line includes: ① Last upload price
.
②The retail price of the highest purchase price of the drug with the same generic name (except for the original research drug or reference preparation) in the designated medical institution is converted by the price difference rate
.
The second is price lock (red line)
.
If the price is higher than the red line, the system will automatically block it
.
The red line includes: ① the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; ② the retail price of the highest purchase price of the designated medical institution of the same product of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
According to Minet.
com's 2022 Blue Book on the Development of China's Pharmaceutical Market, there are currently 4,340 retail pharmacy stores in Shanghai, with a chain rate of 91.
9%, ranking first in the country; the average number of people serving in stores is 5,736, ranking first in the country
.
Under such a situation, a number of policies of the regulatory authorities have sent a signal to the chain pharmacies: the price monitoring of pharmacies will continue to be strengthened, and how to increase the per capita efficiency has become a test faced by many pharmacies
.
In fact, there is a precedent for drug price monitoring to be included in medical insurance plans
.
The National Medical Insurance Administration started drug price monitoring in 2019, but at that time it mainly targeted some varieties, especially drugs in shortage, centralized procurement and negotiation, and did not establish a monitoring system covering medical institutions and pharmacies
.
Regarding the monitoring of drug retail prices, there are relevant experiences in many places
.
In July 2019, the Quanzhou Municipal Medical Insurance Bureau of Fujian Province issued the "Monitoring and Publishing System for the Retail Price Information of Commonly Used Drugs" to monitor the prices of 100 commonly used drugs in 15 designated chain retail pharmacies of Quanzhou, and update and announce the retail prices of drugs on a quarterly basis.
, allowing the public to inquire about the price information of various drugs in a timely manner
.
Through the "price ratio of three", choose retail pharmacies to buy medicines
.
In March 2020, the Ningguoshi Medical Insurance Bureau of Xuancheng City, Anhui Province issued the "Ningguo City Medical Insurance Designated Retail Pharmacy Routine Drug Price Information Monitoring and Release System" to track, collect and release changes in the retail price of conventional drugs in the medical insurance designated retail pharmacies.
Announce activities
.
In addition, more and more places have launched drug price comparison systems, and the attention to drug prices continues to increase
.
Shanghai, Shenzhen, Guangdong, Suqian, Jiangsu and other places have launched drug price inquiry services in retail pharmacies, and introduced corresponding price comparison systems.
Under the main line of medical reform to control drug prices, it is foreseeable that there will be more and more price comparison systems in different forms
.
02 Drug price monitoring benefits many parties.
In fact, drug price differences exist in every channel, online and offline, different pharmacies, different regions, etc.
In recent years, with the rise of online channels, online channels have become more Transparent and convenient, the price difference between online and offline is becoming more prominent
.
The main purpose of the Medical Insurance Bureau's price monitoring is to use publicity, monitoring and other means to deter the phenomenon of inflated prices and price gouging, so that consumers can "comparison of three prices" when choosing drugs, thereby guiding the market to form reasonable prices
.
Price monitoring is one of the important means for price supervision of designated medical insurance pharmacies in various regions
.
In fact, it is also the consensus of the industry that there is no price war and reasonable pricing
.
Standardizing drug prices, for upstream industrial enterprises, can stabilize the market price of drugs, ensure profits, and do not harm drugs; for physical pharmacies, it can guide them to return to the essence of pharmaceutical services, not to fight price wars, but to use professional medical knowledge.
and service ability to retain customers and form a good market competition environment, which is conducive to the better development of the pharmaceutical industry
.
In addition, in today's highly developed Internet, online drug purchase has become the choice of many people, not only for convenience, but also because of "price"
.
Due to the different circulation links of online and offline pharmacies, the operating costs of online pharmacies are often lower than that of physical pharmacies, and the drug prices will also be lower, which will have an impact on the business
of offline pharmacies .
Implementing drug price monitoring can also regulate drug pricing in online pharmacies to a certain extent and stabilize the drug retail market
.
And from the perspective of form, on the basis of full market competition, in order to regulate the intensive, refined and high-quality development of the market, the drug price management of retail pharmacies should be subject to stricter supervision, and regulating the price order of the drug retail market is also a regulatory authority.
one of the focus of the work
.
Medicine01 Implement drug price monitoring in many places Enterprise pharmacies02 Drug price monitoring Lidofang business drugs